Cognitive profiles in dementia
Alzheimer disease vs healthy brain aging
Citation Manager Formats
Make Comment
See Comments
This article requires a subscription to view the full text. If you have a subscription you may use the login form below to view the article. Access to this article can also be purchased.
Abstract
Objective: To re-examine proposed models of cognitive test performance that concluded separate factor structures were required for people with Alzheimer disease (AD) and older adults without dementia.
Methods: Five models of cognitive test performance were compared using multistep confirmatory factor analysis in 115 individuals with autopsy-confirmed AD and 191 research participants without clinical dementia from longitudinal studies at the Washington University AD Research Center. The models were then cross-validated using independent samples of 323 people with clinically diagnosed dementia of the Alzheimer type and 212 cognitively healthy older adults.
Results: After controlling for Alzheimer-specific changes in episodic memory, performance on the battery of tests used here was best represented in people both with and without dementia by a single model of one general factor and three specific factors (verbal memory, visuospatial ability, and working memory). Performance by people with dementia was lower on the general factor than it was by those without dementia. Larger variances associated with the specific factors in the group with dementia indicated greater individual differences in the pattern of cognitive deficits in the stage of AD.
Conclusions: A hybrid model of general and specific cognitive domains simplifies cognitive research by allowing direct comparison of normal aging and Alzheimer disease performance. The presence of a general factor maximizes detection of the dementia, whereas the specific factors reveal the heterogeneity of dementia’s associated cognitive deficits.
GLOSSARY: AD = Alzheimer disease; BD = Block Design; BNT = Boston Naming Test; BVRT = Benton Visual Retention Test; CDR = Clinical Dementia Rating; CFA = confirmatory factor analysis; CFI = comparative fit index; DAT = dementia of the Alzheimer type; DS-B = Digit Span Backward; DS-F = Digit Span Forward; DSym = Digit Symbol; INFO = information; LBs = Lewy bodies; LM = Logical Memory; MC = Mental Control; NIA = National Institute on Aging; PA = Paired Associate Learning; RMSEA = root mean square error of approximation; TOI = tests of invariance; TRA = Trailmaking A; WF = Word Fluency.
Footnotes
-
Supported by National Institute on Aging grants P01 AG03991, P50 AG05681, and K08 AG20764; American Federation for Aging Research; and gifts from the Alan A. and Edith L. Wolff Charitable Trust.
Disclosure: The authors report no disclosures.
Received May 13, 2008. Accepted in final form August 20, 2008.
AAN Members
We have changed the login procedure to improve access between AAN.com and the Neurology journals. If you are experiencing issues, please log out of AAN.com and clear history and cookies. (For instructions by browser, please click the instruction pages below). After clearing, choose preferred Journal and select login for AAN Members. You will be redirected to a login page where you can log in with your AAN ID number and password. When you are returned to the Journal, your name should appear at the top right of the page.
AAN Non-Member Subscribers
Purchase access
For assistance, please contact:
AAN Members (800) 879-1960 or (612) 928-6000 (International)
Non-AAN Member subscribers (800) 638-3030 or (301) 223-2300 option 3, select 1 (international)
Sign Up
Information on how to subscribe to Neurology and Neurology: Clinical Practice can be found here
Purchase
Individual access to articles is available through the Add to Cart option on the article page. Access for 1 day (from the computer you are currently using) is US$ 39.00. Pay-per-view content is for the use of the payee only, and content may not be further distributed by print or electronic means. The payee may view, download, and/or print the article for his/her personal, scholarly, research, and educational use. Distributing copies (electronic or otherwise) of the article is not allowed.
Letters: Rapid online correspondence
REQUIREMENTS
You must ensure that your Disclosures have been updated within the previous six months. Please go to our Submission Site to add or update your Disclosure information.
Your co-authors must send a completed Publishing Agreement Form to Neurology Staff (not necessary for the lead/corresponding author as the form below will suffice) before you upload your comment.
If you are responding to a comment that was written about an article you originally authored:
You (and co-authors) do not need to fill out forms or check disclosures as author forms are still valid
and apply to letter.
Submission specifications:
- Submissions must be < 200 words with < 5 references. Reference 1 must be the article on which you are commenting.
- Submissions should not have more than 5 authors. (Exception: original author replies can include all original authors of the article)
- Submit only on articles published within 6 months of issue date.
- Do not be redundant. Read any comments already posted on the article prior to submission.
- Submitted comments are subject to editing and editor review prior to posting.
You May Also be Interested in
Dr. Jessica Ailani and Dr. Ailna Masters-Israilov
► Watch
Related Articles
- No related articles found.
Topics Discussed
Alert Me
Recommended articles
-
Articles
Relating anatomy to function in Alzheimer's diseaseNeuropsychological profiles predict regional neuropathology 5 years laterS. M. Kanne, D. A. Balota, M. Storandt et al.Neurology, April 01, 1998 -
ARTICLES
Cerebral amyloid deposition and diffuse plaques in ``normal'' agingEvidence for presymptomatic and very mild Alzheimer's diseaseJ. C. Morris, M. Storandt, D. W. McKeel, Jr. et al.Neurology, March 01, 1996 -
Articles
Differentiating frontal and temporal variant frontotemporal dementia from Alzheimer’s diseaseR.J. Perry, J.R. Hodges et al.Neurology, June 27, 2000 -
Article
CSF excitatory amino acids and severity of illness in Alzheimer's diseaseJ. G. Csernansky, M. E. Bardgett, Y. I. Sheline et al.Neurology, June 01, 1996